Effect of Ankle Joint Manipulation on Chronic Ankle Sprain With Compressed Ankle Joint for Volleyball and Basketball Players

November 10, 2026 updated by: yasmein mohammed mahmoud, Kafrelsheikh University

The goal of this pre-post randomized controlled experimental trial is to examine the impact of ankle joint manipulation on chronic ankle sprain with a compressed ankle joint in athletes (identified in the proposal as volleyball, basketball, and tennis players) aged 16 to 45 years of both genders.

The main questions it aims to answer are:

Does ankle joint manipulation effectively reduce pain and improve functional status? Does the treatment successfully increase ankle range of motion (ROM)?

Researchers will compare an experimental group receiving manipulation to a control group receiving no treatment to determine the intervention's effectiveness.

Participants will:

  • Be randomly assigned into two equal groups of 30 patients each.
  • Either receive a one-shot manipulation of the head of the fibula or receive no treatment.
  • Have their ankle range of motion measured using an electronic goniometer.
  • Report their ankle pain levels measured by a numeric analog scale.
  • Complete a functional assessment evaluated by the ankle joint functional index.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Participants must be volleyball, basketball, or tennis players. Participants must have a chronic ankle sprain with a compressed ankle joint. Participants must be within the age range of 16 to 45 years. Participants can be of either gender. Participants must be willing to sign a consent form according to the Helsinki Protocol.

Exclusion Criteria:

  • History of acute severe ankle fractures or previous lower extremity surgeries.
  • Presence of open wounds, skin lesions, or severe dermatological conditions around the ankle or fibula region that contraindicate manual manipulation.
  • Acute systemic inflammatory conditions or arthropathies (such as rheumatoid arthritis or gout).
  • Neurological deficits, severe peripheral neuropathy, or vascular disorders affecting the lower limbs.
  • Receipt of any other physical therapy treatments, injections, or interventions for the ankle within the weeks preceding the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Head of Fibula Manipulation

The intervention consists of a single session ("one shoot") manual manipulation targeting the head of the fibula. This manipulation targets joint compression, often addressing posterior positional faults of the talus, to restore normal arthrokinematics. The procedure is intended to instantly improve dorsiflexion range of motion, reduce anterior impingement pain, and enhance dynamic balance and landing mechanics in athletes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Ankle range of motion measured by an electronic goniometer
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Secondary Outcome Measures

Outcome Measure
Time Frame
Ankle pain measured by a numeric analog scale
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Ankle function assessed by the ankle joint functional index
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohammed Abdelaziz Emam, master degree, Ass.lecturer, faculty of physical therapy, kafr elshiekh university
  • Principal Investigator: Reda Fathi Elbosaty, Bachelor student, faculty of physical therapy, kafr elshiekh university
  • Principal Investigator: Yasmein Mohammed Mahmoud, Ph.D, lecturer, faculty of physical therapy, kafr elshiekh university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 10, 2026

Primary Completion (Estimated)

December 10, 2026

Study Completion (Estimated)

December 11, 2026

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be shared upon reasonable request from the principal investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe